-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
BIOREGENX, INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2021 to 31 Mar 2025.
- BIOREGENX, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $10,415, a 104% decline year-over-year.
- BIOREGENX, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $442,119, a 63% decline from 2023.
- BIOREGENX, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1,204,322, a 2840% increase from 2022.
- BIOREGENX, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $40,970, a 18% decline from 2021.